This compound, an aminoglycoside, is primarily utilized in the development of novel antibiotics and antimicrobial agents due to its complex structure composed of amino sugars, which enables it to bind to the bacterial 30S ribosomal subunit and interfere with protein synthesis, leading to bacterial cell death. This mechanism makes it effective against resistant strains. Additionally, it is being explored for its potential in targeted drug delivery systems, where its specific molecular interactions can enhance the precision of therapeutic agents. Researchers are also investigating its role in glycobiology, particularly in understanding carbohydrate-protein interactions, which are crucial in various biological processes, including immune response and cellular communication. Its unique structure also makes it a candidate for use in the synthesis of bioactive molecules for treating bacterial infections and other diseases.